StonvexLoading…
StonvexStonvexStonvexCore line items from VNCE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Q4 2025 2025-11-01 | Q3 2025 2025-08-02 | Q2 2025 2025-05-03 |
|---|---|---|---|---|
Revenue | $300.01M | $216.30M | $131.17M | $57.93M |
Operating Income | $9.24M | $12.15M | $6.71M | $-4.44M |
Net Income | $6.38M | $9.98M | $12.06M | $-4.80M |
EPS (Diluted) | $0.49 | $0.77 | $0.56 | $-0.37 |
Total Assets | $225.04M | $246.00M | $238.97M | $217.96M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $498.00K | $1.06M | $777.00K | $2.59M |
Free Cash Flow OCF − CapEx | $-1.30M | $-16.85M | $-11.14M | $-13.24M |
Shares Outstanding | 12.85M | 13.34M | 12.97M | 12.85M |